Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
YAP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB2A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MYO10 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RAB35 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
EML2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DAOA-AS1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC284600 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ZBED1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Homologene neighbors
MTRF1L - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
KIAA0141 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MFSD4A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
STX3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
APLP2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TRAK2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SLC9A2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CLN8 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
FNIP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CAPN10 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SLC25A13 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ATP6V0A2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on